B A S E C A R E
Good news丨Basecare won the title of Suzhou "Unicorn" Cultivation Enterprise in 2020
21st Dec 2020 · Suzhou
On December 21, Suzhou Science and Technology Bureau released the list of Suzhou "Unicorn" cultivation enterprises in 2020. Suzhou Basecare Co., Ltd. (hereinafter referred to as "Basecare") was awarded the title of "Unicorn" Cultivation Enterprise in Suzhou. This means that Basecare has been highly recognized and fully affirmed by the relevant departments of the Jiangsu Provincial Government in terms of development potential, innovation capabilities, industry status, and development scale.

On December 21, Suzhou Science and Technology Bureau released the list of Suzhou "Unicorn" cultivation enterprises in 2020. Suzhou Basecare Co., Ltd. (hereinafter referred to as "Basecare") was awarded the title of "Unicorn" Cultivation Enterprise in Suzhou City, which means that Basecare has been highly recognized and fully affirmed by the relevant departments of the Jiangsu Provincial Government in terms of development potential, innovation capabilities, industry status, and development scale.

"Unicorn" enterprises are synonymous with enterprise innovation and development, and an important vane of new economic development. In 2018, Suzhou Municipal Government launched the first "unicorn" enterprise cultivation plan in China, focusing on promoting disruptive innovation, explosive growth, outstanding competitive advantages, and large future development space into "unicorns" Enterprises, build a group of benchmark enterprises for innovation and development, and form the peak of innovation and entrepreneurship in Suzhou. Suzhou strives to create a world-class biomedicine and health industry landmark, and the biomedical industry is a key field for the emergence of "unicorn" cultivation companies.

Suzhou "Unicorn" Cultivation Enterprise in 2020

Preliminary list

Let couples with fertility needs no longer encounter fertility difficulties! As a leading enterprise in the field of reproductive health, Basecare is committed to promoting the popularity of the PGT-A technology. The preimplantation genetic testing for aneuploidy kit (PGT-A kit) produced by Basecare is the first PGT-A product in China that has obtained the “special approval for innovative medical devices”. The test kit also obtained the industry’s first medical device registration certificate (Approval No.: 20203400181), filling the technical gap in the clinical application of preimplantation genetic testing technology in China, marking the beginning of a new era, in which China’s preimplantation genetic testing technology is licensed and under official supervision. The selection of the Suzhou "Unicorn" cultivation enterprise this time represents the high recognition of the strength and potential of Basecare by the Suzhou Municipal Government, and it is also the unremitting driving force for Basecare to move forward in the future.

With its core advantages in the field of PGT, Basecare has extended its antennae from the pre-implantation stage to the pre- and post-natal stages, and is developing kits for each stage, and will complete 4 fertility genetic industry chains in the next 5 years The registration of products has continuously promoted the development of China's preimplantation genetic testing industry. Adhering to the mission of " HELP MORE FAMILIES HAVE HEALTHY BABIES", we will continue to focus on the application and research of genetic technology in the field of fertility, helping infertile patients "be able to give birth", and letting patients with inherited diseases choosing the embryo that does not carry pathogenic genes in the future. Contribute to the national and national eugenics, and keep on marching towards the international brand in the field of reproduction.